Lucinda Y. Quan - Executive Vice President, Chief Business Officer and General Counsel at Aligos Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Executive Vice President, Chief Business Officer and General Counsel
Issuer Symbol
ALGS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Lucinda Y. Quan since 12 Mar 2025

Holdings reported by Lucinda Y. Quan for Aligos Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 48,000 08 Sep 2023 Direct Common Stock

Transactions reported by Lucinda Y. Quan for Aligos Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.